HMO shape the gut microbiome in infants with CMPA

Dr Heine briefly summarised the findings of the TEDDY study, which characterised determinants of early microbiome development. Particular attention was paid to the influence of breast milk and 2’-fucosyllactose. This was followed by an analysis of microbiome data from the multicentre CINNAMON study, which investigated growth, tolerance, and safety of whey-based extensive hydrolysed formulas containing 2’-fucosyllactose and lacto-N-neotetraose in infants with CMPA.